StonvexLoading…
StonvexStonvexStonvexCore line items from SWKS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-10-03 | Annual 2024 2024-09-27 | Annual 2023 2023-09-29 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $4.09B | $4.18B | $4.77B | $5.49B |
Operating Income | $500.00M | $637.40M | $1.13B | $1.53B |
Net Income | $477.10M | $596.00M | $982.80M | $1.28B |
EPS (Diluted) | $3.08 | $3.69 | $6.13 | $7.81 |
Total Assets | $7.92B | $8.28B | $8.43B | $8.87B |
Total Liabilities | $2.16B | $1.95B | $2.34B | $3.40B |
Cash & Equivalents | $1.16B | $1.37B | $718.80M | $566.00M |
Free Cash Flow OCF − CapEx | $1.11B | $1.67B | $1.65B | $935.20M |
Shares Outstanding | 148.70M | 159.90M | 159.50M | 160.20M |